This document summarizes substance abuse issues faced in emergency departments. It notes that substance abuse patients are frequent emergency department users who require significant resources. Over 5 million emergency department visits annually are related to drugs, including 2.5 million specifically for drug abuse or misuse. Prescription opioid abuse and overdoses have risen dramatically in recent years. New CDC guidelines aim to curb opioid prescribing practices to help address this crisis. Emergency physicians are on the front lines of this issue and see the consequences of opioid addiction firsthand.
This document discusses the use of poison center data to track trends in prescription drug abuse and overdoses. It shows that between 1999-2011, prescription opioid exposures reported to poison centers increased over 150% in the US and 164% in Kentucky. Specific opioids like oxycodone, hydrocodone, and tramadol also increased substantially. Poison center data can provide real-time surveillance to identify emerging problems and formulate strategies to address them.
This document discusses strategies to curb prescription drug abuse, specifically opioid abuse, in West Virginia. It notes that West Virginia has the highest drug overdose mortality rate in the US and clinicians there write a high number of opioid prescriptions. It explores reasons for high prescribing rates and discusses solutions like improving education for patients and doctors, changing financial incentives, using prescription drug monitoring programs, and following CDC guidelines for safer opioid prescribing. Alternative therapies for pain management and the role of EDIE in monitoring patients and interfacing with PDMPs are also covered. The document advocates for internal referrals to pain specialists and multidisciplinary approaches to pain care.
The document discusses efforts to address the opioid epidemic in the United States, including:
- Increasing registration and use of prescription drug monitoring programs (PDMPs) to track opioid prescriptions.
- Reducing the stigma around both pain and substance use disorder to increase access to comprehensive treatment.
- Expanding access to naloxone to prevent overdose deaths and "Good Samaritan" legal protections.
- Ongoing education of physicians on safe opioid prescribing and alternative pain management strategies.
The document summarizes the opioid epidemic in the United States and the response from the Department of Health and Human Services (HHS). It provides data showing that prescription opioids are the most commonly abused drugs and that opioid overdose deaths have increased significantly since 1999. The HHS Secretary launched an Opioid Initiative in 2015 focused on improving opioid prescribing practices, increasing access to naloxone to reverse overdoses, and expanding medication-assisted treatment for opioid use disorders. Partnerships with health organizations aim to train providers and increase access to prevention and treatment services. States like Washington that implemented comprehensive approaches have seen declines in overdose deaths and hospitalizations.
This document discusses the use of poison center data to track trends in prescription drug abuse and overdoses. It shows that between 1999-2011, prescription opioid exposures reported to poison centers increased over 150% in the US and 164% in Kentucky. Specific opioids like oxycodone, hydrocodone, and tramadol also increased substantially. Poison center data can provide real-time surveillance to identify emerging problems and formulate strategies to address them.
This document discusses strategies to curb prescription drug abuse, specifically opioid abuse, in West Virginia. It notes that West Virginia has the highest drug overdose mortality rate in the US and clinicians there write a high number of opioid prescriptions. It explores reasons for high prescribing rates and discusses solutions like improving education for patients and doctors, changing financial incentives, using prescription drug monitoring programs, and following CDC guidelines for safer opioid prescribing. Alternative therapies for pain management and the role of EDIE in monitoring patients and interfacing with PDMPs are also covered. The document advocates for internal referrals to pain specialists and multidisciplinary approaches to pain care.
The document discusses efforts to address the opioid epidemic in the United States, including:
- Increasing registration and use of prescription drug monitoring programs (PDMPs) to track opioid prescriptions.
- Reducing the stigma around both pain and substance use disorder to increase access to comprehensive treatment.
- Expanding access to naloxone to prevent overdose deaths and "Good Samaritan" legal protections.
- Ongoing education of physicians on safe opioid prescribing and alternative pain management strategies.
The document summarizes the opioid epidemic in the United States and the response from the Department of Health and Human Services (HHS). It provides data showing that prescription opioids are the most commonly abused drugs and that opioid overdose deaths have increased significantly since 1999. The HHS Secretary launched an Opioid Initiative in 2015 focused on improving opioid prescribing practices, increasing access to naloxone to reverse overdoses, and expanding medication-assisted treatment for opioid use disorders. Partnerships with health organizations aim to train providers and increase access to prevention and treatment services. States like Washington that implemented comprehensive approaches have seen declines in overdose deaths and hospitalizations.
This document summarizes opioid prescribing trends, policies, and their impacts in Canada and at the US-Canada border. It finds that while Canada and the US have high opioid consumption, Canadian policies like introducing tamper-deterrent OxyContin and a prescription monitoring program reduced potentially inappropriate prescribing by 1%. However, over 1 million such prescriptions remain, and inconsistencies in provincial policies and lack of prescriber access to prescription data limit the policies. The approval of generic long-acting oxycodone in Canada did not increase trafficking into the US, though losses cannot be tracked. Ongoing evaluation is needed to improve policies around opioid availability and curb misuse across the border.
Dr. Tom Frieden, Director of the Centers for Disease Control and Prevention, keynote presentation at the National Rx Drug Abuse & Heroin Summit on March 30, 2016.
This document summarizes the opioid crisis in the United States from 2000 to 2014. It shows that the number of opioid-related overdose deaths more than tripled during this period, increasing from about 8,000 to over 28,000. Additionally, 7.9 million Americans aged 12 or older met the criteria for an illicit drug use disorder in 2013-2014 but only 20% received treatment. The document outlines actions by the Obama administration to address the crisis and increase funding for treatment. It emphasizes that stories can help reduce stigma and that recovery is possible through working together.
Rx16 federal tues_330_1_spitznas_2baldwin_3welchOPUNITE
This document discusses patient review and restriction programs (PRRs) as tools to help curb prescription drug abuse and coordinate patient care. It describes state Medicaid PRR programs and recent efforts to expand PRR programs to Medicare. It also describes the role of PRR programs in the CDC's Prescription Drug Overdose Prevention for States grant program, the Office of National Drug Control Policy's national strategy, and the federal budget.
This document summarizes a presentation on drugs to watch including tramadol, hydrocodone, and naloxone. It includes:
- Disclosures from presenters declaring no conflicts of interest.
- Learning objectives focused on analyzing the impact of schedule changes for tramadol and hydrocodone, educating on tramadol dangers, and evaluating pharmacist perspectives on naloxone.
- Information presented on the drugs including their classifications, potencies, risks of abuse and addiction, and impacts of rescheduling hydrocodone and tramadol in California. Data showed decreased hydrocodone prescriptions but increased tramadol and overall opioid prescriptions, as well as increased over
Rx16 federal tues_200_1_gladden_2halpin_3greenOPUNITE
This document provides information about the emerging fentanyl overdose epidemic in the United States from the national and state perspectives. It discusses the rise in fentanyl-related overdoses and seizures from 2013-2014 according to data from various sources. The learning objectives are to explain the epidemiology of the rise in fentanyl overdoses, identify lessons from an Ohio investigation, and describe one state's experience. Recommendations include improving detection of fentanyl through testing and surveillance, expanding naloxone access, and long-term efforts to reduce opioid overdoses through prescribing guidelines and treatment expansion.
This document summarizes two presentations on treatment of opioid use disorders given at the National Prescription Drug Abuse Summit in 2014.
The first presentation outlines the risks of current inpatient opioid detoxification methods and benefits of evidence-based alternatives. It also examines opportunities for stakeholders to impact opioid addiction education.
The second presentation discusses innovations in buprenorphine treatment, including collaborative care models, group practice models, and strategies to address high-risk patients prescribed buprenorphine in office-based opioid treatment settings. Buprenorphine prescriber shortages, standards, retention challenges, and predictors of positive outcomes are also reviewed.
The abuse of prescription painkillers and illicit opioids has become a public health concern in the United States of America. The Centers for Disease Control and Prevention (CDC) reports that more than 1,000 Americans are given treatment in emergency departments every day for misusing prescription opioids.
This document summarizes a presentation on medication-assisted treatment for opioid addiction. It discusses the history of treatment approaches, including the development of methadone and buprenorphine maintenance therapies. Studies show that agonist therapies like methadone and buprenorphine are more effective at retaining patients in treatment and reducing illicit opioid use than non-medication approaches. While both methadone and buprenorphine are effective, buprenorphine has a safer side effect profile but its effectiveness may be limited by lower monitoring and adherence compared to methadone treatment. The document reviews several studies demonstrating the benefits of long-term agonist therapy over detoxification or short-term medication approaches for opioid
This document summarizes a presentation on managing morphine equivalent dose (MED) and identifying high-risk opioid use through "red flagging." It discusses how calculating MED at the point of sale can help identify unsafe dosages and decrease opioid prescriptions. It also evaluates different methods to screen for overdose risk, finding that simple opioid use thresholds to flag patients may not accurately target those most likely to experience preventable overdoses. The presentation aims to explain MED management, describe payer solutions that reduced opioid use, and identify more precise ways to intervene with highest-risk patients.
This document summarizes trends shaping workers' compensation medication policies in 2014. It discusses the influence of various factors, including political influences from the Affordable Care Act and state elections; clinical influences like an aging population and the opioid epidemic; and product influences as new medications enter the market. It also outlines debates around issues like physician dispensing, compounded medications, medical marijuana, and opioid monitoring programs.
This document discusses a presentation on whether pharmacists should fill opioid prescriptions or not. It includes the presenters, learning objectives, and disclosures. It then summarizes Karen Ryle's presentation on red flags pharmacists should watch out for when dispensing controlled substances like opioids. These include things like "cocktailed" prescriptions, no individualized dosing, early refills, out-of-area doctors and patients, and mostly cash prescriptions. It also discusses integrating prescription drug monitoring program data into pharmacy workflows to more easily check for signs of abuse or diversion.
The document discusses barriers to medication-assisted treatment (MAT) for opioid use disorder (OUD) and strategies to overcome them. It outlines a 5-point strategy from HHS, screening and assessment tools for OUD, treatments including mutual help programs and medications like methadone, buprenorphine, and naltrexone, and barriers in the treatment system, among patients, and among medical providers. It also provides details on administering and prescribing the three medications, assessing patients' need for treatment, and integrating MAT into successful outpatient treatment for OUD.
Crime is defined as an act or omission committed against the community that is punishable by the state. What constitutes a crime can vary between jurisdictions and is influenced by a society's values, morals, religion, culture, history, and legal traditions. Sometimes laws need reforming to remove outdated crimes or create new crimes to address changes in society, like computer crimes. The features of criminal law are protecting society, prosecuting crimes against people, the state, or property, where the state takes action against offenders through police prosecution in court under the burden of proof of beyond a reasonable doubt.
Lesson One - Introduction into sociologyaqsa_naeem
This document provides an introduction to key concepts in sociology. It defines sociology as the study of social behaviors and explains that sociologists explore human social interactions through studying relationships between individuals, groups, and social institutions. Some key points:
- Sociology examines how social institutions like family, education, work, health care influence behaviors and how people are socialized from a young age.
- It explores different sociological perspectives like functionalism, Marxism, feminism to analyze topics like crime, family, media.
- Social diversity and social structure influence individuals, but sociologists take different theoretical approaches like structuralism which emphasize social control versus action theory focusing on individual agency.
This document summarizes opioid prescribing trends, policies, and their impacts in Canada and at the US-Canada border. It finds that while Canada and the US have high opioid consumption, Canadian policies like introducing tamper-deterrent OxyContin and a prescription monitoring program reduced potentially inappropriate prescribing by 1%. However, over 1 million such prescriptions remain, and inconsistencies in provincial policies and lack of prescriber access to prescription data limit the policies. The approval of generic long-acting oxycodone in Canada did not increase trafficking into the US, though losses cannot be tracked. Ongoing evaluation is needed to improve policies around opioid availability and curb misuse across the border.
Dr. Tom Frieden, Director of the Centers for Disease Control and Prevention, keynote presentation at the National Rx Drug Abuse & Heroin Summit on March 30, 2016.
This document summarizes the opioid crisis in the United States from 2000 to 2014. It shows that the number of opioid-related overdose deaths more than tripled during this period, increasing from about 8,000 to over 28,000. Additionally, 7.9 million Americans aged 12 or older met the criteria for an illicit drug use disorder in 2013-2014 but only 20% received treatment. The document outlines actions by the Obama administration to address the crisis and increase funding for treatment. It emphasizes that stories can help reduce stigma and that recovery is possible through working together.
Rx16 federal tues_330_1_spitznas_2baldwin_3welchOPUNITE
This document discusses patient review and restriction programs (PRRs) as tools to help curb prescription drug abuse and coordinate patient care. It describes state Medicaid PRR programs and recent efforts to expand PRR programs to Medicare. It also describes the role of PRR programs in the CDC's Prescription Drug Overdose Prevention for States grant program, the Office of National Drug Control Policy's national strategy, and the federal budget.
This document summarizes a presentation on drugs to watch including tramadol, hydrocodone, and naloxone. It includes:
- Disclosures from presenters declaring no conflicts of interest.
- Learning objectives focused on analyzing the impact of schedule changes for tramadol and hydrocodone, educating on tramadol dangers, and evaluating pharmacist perspectives on naloxone.
- Information presented on the drugs including their classifications, potencies, risks of abuse and addiction, and impacts of rescheduling hydrocodone and tramadol in California. Data showed decreased hydrocodone prescriptions but increased tramadol and overall opioid prescriptions, as well as increased over
Rx16 federal tues_200_1_gladden_2halpin_3greenOPUNITE
This document provides information about the emerging fentanyl overdose epidemic in the United States from the national and state perspectives. It discusses the rise in fentanyl-related overdoses and seizures from 2013-2014 according to data from various sources. The learning objectives are to explain the epidemiology of the rise in fentanyl overdoses, identify lessons from an Ohio investigation, and describe one state's experience. Recommendations include improving detection of fentanyl through testing and surveillance, expanding naloxone access, and long-term efforts to reduce opioid overdoses through prescribing guidelines and treatment expansion.
This document summarizes two presentations on treatment of opioid use disorders given at the National Prescription Drug Abuse Summit in 2014.
The first presentation outlines the risks of current inpatient opioid detoxification methods and benefits of evidence-based alternatives. It also examines opportunities for stakeholders to impact opioid addiction education.
The second presentation discusses innovations in buprenorphine treatment, including collaborative care models, group practice models, and strategies to address high-risk patients prescribed buprenorphine in office-based opioid treatment settings. Buprenorphine prescriber shortages, standards, retention challenges, and predictors of positive outcomes are also reviewed.
The abuse of prescription painkillers and illicit opioids has become a public health concern in the United States of America. The Centers for Disease Control and Prevention (CDC) reports that more than 1,000 Americans are given treatment in emergency departments every day for misusing prescription opioids.
This document summarizes a presentation on medication-assisted treatment for opioid addiction. It discusses the history of treatment approaches, including the development of methadone and buprenorphine maintenance therapies. Studies show that agonist therapies like methadone and buprenorphine are more effective at retaining patients in treatment and reducing illicit opioid use than non-medication approaches. While both methadone and buprenorphine are effective, buprenorphine has a safer side effect profile but its effectiveness may be limited by lower monitoring and adherence compared to methadone treatment. The document reviews several studies demonstrating the benefits of long-term agonist therapy over detoxification or short-term medication approaches for opioid
This document summarizes a presentation on managing morphine equivalent dose (MED) and identifying high-risk opioid use through "red flagging." It discusses how calculating MED at the point of sale can help identify unsafe dosages and decrease opioid prescriptions. It also evaluates different methods to screen for overdose risk, finding that simple opioid use thresholds to flag patients may not accurately target those most likely to experience preventable overdoses. The presentation aims to explain MED management, describe payer solutions that reduced opioid use, and identify more precise ways to intervene with highest-risk patients.
This document summarizes trends shaping workers' compensation medication policies in 2014. It discusses the influence of various factors, including political influences from the Affordable Care Act and state elections; clinical influences like an aging population and the opioid epidemic; and product influences as new medications enter the market. It also outlines debates around issues like physician dispensing, compounded medications, medical marijuana, and opioid monitoring programs.
This document discusses a presentation on whether pharmacists should fill opioid prescriptions or not. It includes the presenters, learning objectives, and disclosures. It then summarizes Karen Ryle's presentation on red flags pharmacists should watch out for when dispensing controlled substances like opioids. These include things like "cocktailed" prescriptions, no individualized dosing, early refills, out-of-area doctors and patients, and mostly cash prescriptions. It also discusses integrating prescription drug monitoring program data into pharmacy workflows to more easily check for signs of abuse or diversion.
The document discusses barriers to medication-assisted treatment (MAT) for opioid use disorder (OUD) and strategies to overcome them. It outlines a 5-point strategy from HHS, screening and assessment tools for OUD, treatments including mutual help programs and medications like methadone, buprenorphine, and naltrexone, and barriers in the treatment system, among patients, and among medical providers. It also provides details on administering and prescribing the three medications, assessing patients' need for treatment, and integrating MAT into successful outpatient treatment for OUD.
Crime is defined as an act or omission committed against the community that is punishable by the state. What constitutes a crime can vary between jurisdictions and is influenced by a society's values, morals, religion, culture, history, and legal traditions. Sometimes laws need reforming to remove outdated crimes or create new crimes to address changes in society, like computer crimes. The features of criminal law are protecting society, prosecuting crimes against people, the state, or property, where the state takes action against offenders through police prosecution in court under the burden of proof of beyond a reasonable doubt.
Lesson One - Introduction into sociologyaqsa_naeem
This document provides an introduction to key concepts in sociology. It defines sociology as the study of social behaviors and explains that sociologists explore human social interactions through studying relationships between individuals, groups, and social institutions. Some key points:
- Sociology examines how social institutions like family, education, work, health care influence behaviors and how people are socialized from a young age.
- It explores different sociological perspectives like functionalism, Marxism, feminism to analyze topics like crime, family, media.
- Social diversity and social structure influence individuals, but sociologists take different theoretical approaches like structuralism which emphasize social control versus action theory focusing on individual agency.
Social institutions are phenomena that account for enduring and repetitive social structures. They develop gradually and unplanned over time to meet important societal needs like providing new members, socializing children, addressing health issues, assigning jobs, creating knowledge, and promoting social unity. Social institutions tend to be conservative and change slowly due to being legitimized as logical and natural. A change in one institution can impact others due to their interdependence. While fulfilling core functions, the specific form of institutions differs between societies.
This document provides an overview of social stratification and related concepts. It discusses the meaning and types of social stratification including caste system, class system, and race. It then focuses on the Indian caste system, outlining theories about its origin and key features both historically and in modern India. The document also addresses social class and status, social mobility, and how class, caste, and race can influence health and health practices.
Sociology is the study of human society and social interaction. It was coined by Auguste Comte in 1839 and is considered the youngest of the social sciences. There are two main perspectives on the scope of sociology - the specialist/formalistic school views it as studying specific aspects of human relationships, while the synthetic school sees it as studying all aspects of society. Sociology is important for nursing as most illnesses have social causes and consequences. Understanding sociology helps nurses deal with patients by comprehending their habits, norms, culture and behaviors. It also aids in understanding the social factors influencing health and barriers to treatment. Nurses can apply sociological knowledge to approach patients on emotional, cultural and intellectual levels.
Culture is an important concept in sociology and is defined in various ways by different sociologists. Culture includes knowledge, beliefs, arts, morals, customs, and other capabilities acquired by humans as members of society. It is learned and transmitted between generations. Culture has both material and non-material aspects. It is shared within a group and influences human behavior. Culture is also changing over time as it adapts to different environments.
This document summarizes many important laws and rights for women in India. It outlines legislation related to dowry, domestic violence, sexual harassment, and more. It also describes legal rights for women regarding filing police reports, healthcare access, and protections for rape victims. Additionally, it covers rights in live-in relationships, harassment, stalking, cruelty, and maintenance and benefits related to marriage, children, and maternity leave.
This document discusses social institutions and defines them as structured social groups that govern members' behavior and promote social order and cooperation. It examines the key characteristics and functions of institutions, including simplifying social behavior, providing social roles and relations, coordinating stability, and controlling behavior. The major social institutions discussed are the family, education, religion, economic institutions, and government. For each institution, the document outlines their defining features, roles, and how they socialize groups.
This document provides an overview of addiction and substance use. It defines addiction as a chronic disease involving brain circuits, genetics, environment and life experiences. It discusses types of addiction including substance and behavioral addiction. Common addictions include tobacco, alcohol, drugs, gambling, food, video games and internet. The document reviews prevalence data on addiction from various sources. It also discusses treatment approaches for behavioral and substance use disorders including detox, individual therapy, group therapy and rehabilitation programs. Recent studies on substance use during the COVID-19 pandemic are also summarized.
This document provides an overview of a conference on chronic pain and addiction that will take place from April 10-12, 2012 at Walt Disney World Swan Resort. The conference will focus on prescription drug abuse in the US, the effects of prescription pain medication abuse over time, and advocating for continued education on addiction for pain management providers. Key statistics on prescription drug abuse in the US are presented, including that opioid analgesics are now the leading cause of accidental drug overdose deaths. Abuse of prescription drugs is rising among both adolescents and older adults.
EVERFI Webinar: Evidence Based Prescription Drugs ProgramMichele Collu
This document provides an overview of EVERFI's new prescription drug abuse prevention course. It discusses the opioid epidemic in the United States and risk factors for prescription drug misuse among college students. The course is designed using behavioral theories and focuses on increasing knowledge of prescription drugs, teaching refusal skills, and encouraging safe usage as advised by medical professionals. The goal is to implement an evidence-informed prevention program to address this public health issue.
Drug abuse is a growing problem globally and in Nepal. It has serious physical, psychological, and social effects. There are many factors that contribute to drug abuse including biological predispositions, psychological factors like curiosity, and social determinants like peer pressure, family problems, and easy access. In Nepal, the most commonly abused drugs include alcohol, cannabis, heroin, and prescription opioids. Most users are male youth between ages 15-29 with secondary education or less. Multiple approaches are needed to understand and address the complex etiology of drug abuse.
Rational Drug use - Group 5 presentation 2.0 bello editCipriano Bello
The slide is about rational use of drugs, what influences it, factors and reasons, strategies to improve them, and choosing an intervention (WHO priorities).
This document discusses the growing epidemic of prescription opioid addiction among women in Ontario. Some key points:
- Prescription opioid misuse has risen dramatically in Ontario over the last decade, with close to 39,000 individuals now on methadone treatment. Women are particularly at risk given higher prescription rates and faster progression to addiction.
- Women experience higher rates of chronic pain conditions and are more likely to be prescribed and continue taking opioids long-term, putting them at increased risk of addiction. A host of social and biological factors like relationships, trauma history, and concurrent mental health issues can also accelerate a woman's progression to opioid dependence.
- Effective treatment needs to address the underlying risk factors like trauma, mental health issues,
As presented at The Royal by:
- Dr. Melanie Willows, Clinical Director, SUCD Program, The Royal
- Dr. Kim Corace, Director, Program Development and Research, SUCD Program, The Royal
Opioid addiction is a large and growing problem affecting our community, especially our young people, women and their families. This session addressed:
· The current state of prescription opioid problems
· Opioid use, abuse, and addiction as it relates to women and parenting
· Risk factors for opioid use about women, with a focus on mental health problems
· Treatment options to help women who struggle with opioid problems
· Reducing the stigma and myths regarding women with opioid use problems
Characteristics and Outcomes of Adult Opiate Users in Abstinence-Based Resid...Siobhan Morse
Prior research in this population suggests that, overall, opiate and non-opiate addicted users have different issues and ought to be treated differently for their addiction—and that young and older adult opiate users present at treatment with different issues. This study investigated what significant differences in treatment motivation, length and outcome, if any, exist between opiate and non-opiate users and further investigates young adult (18-25 years of age) and older adult (26 and older) opiate users and the impact of any differences. Data for this study was drawn from 1972 individuals who entered voluntary, private, residential drug treatment and rehab. Study measures included the Addiction Severity Index (ASI), the Treatment Service Review (TSR), and the University of Rhode Island Change Assessment (URICA). Interviews were conducted at program intake and six-months post-discharge. Implications for addiction treatment providers and planners are discussed.
The document discusses World Drug Day which is observed annually on June 26th to raise awareness of the global drug problem. It notes that better knowledge is needed to address the drug issue and foster international cooperation. It then provides information on common reasons for teen drug use, latest drug trends including increasing opioid and stimulant abuse, and the impacts of COVID-19 on drug production, trafficking and use. Finally, it outlines the responsibilities of pharmacists in preventing substance abuse through education, monitoring programs, and discouraging overprescribing.
Antonio Boone of the Office of HIV Planning reviewed major points from the Mayor's Task Force to Combat the Opioid Epidemic in Philadelphia at the June 12, 2017 Positive Committee meeting.
Addiction Medicine: Closing the Gap between Science and PracticeCenter on Addiction
These slides accompany CASAColumbia's report, Addiction Medicine: Closing the Gap between Science and Practice, published in June 2012, which found that, despite the prevalence of addiction, the enormity of its consequences, the availability of effective solutions and the evidence that addiction is a disease, both screening and early intervention for risky substance use are rare, and only about 1 in 10 people with addiction involving alcohol or drugs other than nicotine receive any form of treatment.
This document summarizes a presentation on data-driven trends related to prescription drug abuse. It outlines national trends in doctor shopping, overdoses, drugged driving, and opioid/heroin overdose deaths. It also evaluates the effectiveness of some state laws and programs aimed at reducing doctor shopping and responding to overdoses. Some promising policy strategies discussed include reducing inappropriate prescribing, focusing on overdose response, improving prescription drug monitoring programs, and linking overdose victims to treatment.
Optimising Medicine Use, Professor Graham Davies, King's College LondonKCL_commsunit
This document discusses optimizing medicine use and the role of pharmacists. It notes that while medicines can be beneficial, they can also cause harm through adverse drug reactions and non-adherence. Adverse drug reactions account for 6.5% of hospital admissions annually and cost the NHS £466 million per year. Pharmacists can help by identifying medication problems using their knowledge of the patient, medicines, potential interactions and side effects. They establish therapeutic relationships to assess patients, create care plans, and evaluate outcomes with the goal of resolving issues and preventing future problems to deliver safe and effective care.
The director of the CDC discussed the prescription drug and opioid overdose epidemic in the United States. He noted that over 145,000 lives have been lost to prescription opioid overdoses in the past decade as opioid prescribing has increased 4-fold since 1999. The CDC is working with multiple states experiencing outbreaks of HIV linked to injection drug use. The director outlined a potential "technical package" of interventions including improving prescribing practices, increasing access to treatment, reducing drug availability, and public awareness campaigns. Progress requires a comprehensive, evidence-based public health approach with law enforcement and community involvement.
This document discusses essentials of methadone prescribing and treatment for opioid dependence. It covers topics such as the harms of illegal opioid use, drug dependence, opioid dependence, and treatment approaches. Methadone treatment aims to reduce opioid use and related harms through a public health approach. Guidelines are provided for effective methadone programs which seek to improve health, social functioning, and quality of life for those with opioid dependence.
This document summarizes a presentation on engaging physicians in prevention efforts to address the opioid epidemic. It was presented by Yngvild Olsen and included the following key points:
1. Multiple policies like PDMPs, medication-assisted treatment, and naloxone access need to work together to reduce opioid misuse and overdoses.
2. Programs that educate physicians about prescription drug abuse and its link to heroin, and engage them in prevention, screening, and treatment can help address the epidemic.
3. Expanding access to evidence-based treatment with medications like buprenorphine and naloxone, combined with behavioral therapies, can help manage opioid addiction as a chronic disease
This chapter discusses drug use in contemporary society. It notes that nearly every American has used a mind-altering substance such as alcohol, cigarettes, or caffeine. It provides statistics on drug use from national surveys. It discusses the health, social, and economic costs of drug use as well as patterns of drug taking and the extent of drug use according to national surveys. It also covers topics like drug use and education/employment outcomes, drug testing policies, and the large illegal drug business.
SBIRT and SAMHSA's 8 Strategic Initiativessideponytail
Slides from a webinar held by the National SBIRT ATTC. Video is on TheIRETAChannel on Youtube: http://www.youtube.com/watch?v=f6NrKuGlGRs&feature=share&list=PLiML4AFpuB72LBaPShcu2yQv_WpsGY9a9
Treatment Programs HARPS Program (Helping At-Risk Pregnant Women Succeed) - C...ErikaAGoyer
NATIONAL PERINATAL ASSOCIATION CONFERENCE 2014 - Treatment Programs HARPS Program (Helping At-Risk Pregnant Women Succeed)
- Chris Cooper, MSN, NNP-CB, APRN and Dawn Forbes, MD
KEY Points of Leicester travel clinic In London doc.docxNX Healthcare
In order to protect visitors' safety and wellbeing, Travel Clinic Leicester offers a wide range of travel-related health treatments, including individualized counseling and vaccines. Our team of medical experts specializes in getting people ready for international travel, with a particular emphasis on vaccines and health consultations to prevent travel-related illnesses. We provide a range of travel-related services, such as health concerns unique to a trip, prevention of malaria, and travel-related medical supplies. Our clinic is dedicated to providing top-notch care, keeping abreast of the most recent recommendations for vaccinations and travel health precautions. The goal of Travel Clinic Leicester is to keep you safe and well-rested no matter what kind of travel you choose—business, pleasure, or adventure.
Under Pressure : Kenneth Kruk's StrategyKenneth Kruk
Kenneth Kruk's story of transforming challenges into opportunities by leading successful medical record transitions and bridging scientific knowledge gaps during COVID-19.
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...The Lifesciences Magazine
Deep Leg Vein Thrombosis occurs when a blood clot forms in one or more of the deep veins in the legs. These clots can impede blood flow, leading to severe complications.
Stem Cell Solutions: Dr. David Greene's Path to Non-Surgical Cardiac CareDr. David Greene Arizona
Explore the groundbreaking work of Dr. David Greene, a pioneer in regenerative medicine, who is revolutionizing the field of cardiology through stem cell therapy in Arizona. This ppt delves into how Dr. Greene's innovative approach is providing non-surgical, effective treatments for heart disease, using the body's own cells to repair heart damage and improve patient outcomes. Learn about the science behind stem cell therapy, its benefits over traditional cardiac surgeries, and the promising future it holds for modern medicine. Join us as we uncover how Dr. Greene's commitment to stem cell research and therapy is setting new standards in healthcare and offering new hope to cardiac patients.
This particular slides consist of- what is Pneumothorax,what are it's causes and it's effect on body, risk factors, symptoms,complications, diagnosis and role of physiotherapy in it.
This slide is very helpful for physiotherapy students and also for other medical and healthcare students.
Here is a summary of Pneumothorax:
Pneumothorax, also known as a collapsed lung, is a condition that occurs when air leaks into the space between the lung and chest wall. This air buildup puts pressure on the lung, preventing it from expanding fully when you breathe. A pneumothorax can cause a complete or partial collapse of the lung.
International Cancer Survivors Day is celebrated during June, placing the spotlight not only on cancer survivors, but also their caregivers.
CANSA has compiled a list of tips and guidelines of support:
https://cansa.org.za/who-cares-for-cancer-patients-caregivers/
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to CareVITASAuthor
This webinar helps clinicians understand the unique healthcare needs of the LGBTQ+ community, primarily in relation to end-of-life care. Topics include social and cultural background and challenges, healthcare disparities, advanced care planning, and strategies for reaching the community and improving quality of care.
The best massage spa Ajman is Chandrima Spa Ajman, which was founded in 2023 and is exclusively for men 24 hours a day. As of right now, our parent firm has been providing massage services to over 50,000+ clients in Ajman for the past 10 years. It has about 8+ branches. This demonstrates that Chandrima Spa Ajman is among the most reasonably priced spas in Ajman and the ideal place to unwind and rejuvenate. We provide a wide range of Spa massage treatments, including Indian, Pakistani, Kerala, Malayali, and body-to-body massages. Numerous massage techniques are available, including deep tissue, Swedish, Thai, Russian, and hot stone massages. Our massage therapists produce genuinely unique treatments that generate a revitalized sense of inner serenely by fusing modern techniques, the cleanest natural substances, and traditional holistic therapists.
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondHealth Catalyst
Join us as we delve into the crucial realm of quality reporting for MSSP (Medicare Shared Savings Program) Accountable Care Organizations (ACOs).
In this session, we will explore how a robust quality management solution can empower your organization to meet regulatory requirements and improve processes for MIPS reporting and internal quality programs. Learn how our MeasureAble application enables compliance and fosters continuous improvement.
Trauma Outpatient Center is a comprehensive facility dedicated to addressing mental health challenges and providing medication-assisted treatment. We offer a diverse range of services aimed at assisting individuals in overcoming addiction, mental health disorders, and related obstacles. Our team consists of seasoned professionals who are both experienced and compassionate, committed to delivering the highest standard of care to our clients. By utilizing evidence-based treatment methods, we strive to help our clients achieve their goals and lead healthier, more fulfilling lives.
Our mission is to provide a safe and supportive environment where our clients can receive the highest quality of care. We are dedicated to assisting our clients in reaching their objectives and improving their overall well-being. We prioritize our clients' needs and individualize treatment plans to ensure they receive tailored care. Our approach is rooted in evidence-based practices proven effective in treating addiction and mental health disorders.
Dr. David Greene R3 stem cell Breakthroughs: Stem Cell Therapy in CardiologyR3 Stem Cell
Dr. David Greene, founder and CEO of R3 Stem Cell, is at the forefront of groundbreaking research in the field of cardiology, focusing on the transformative potential of stem cell therapy. His latest work emphasizes innovative approaches to treating heart disease, aiming to repair damaged heart tissue and improve heart function through the use of advanced stem cell techniques. This research promises not only to enhance the quality of life for patients with chronic heart conditions but also to pave the way for new, more effective treatments. Dr. Greene's work is notable for its focus on safety, efficacy, and the potential to significantly reduce the need for invasive surgeries and long-term medication, positioning stem cell therapy as a key player in the future of cardiac care.
Healthy Eating Habits:
Understanding Nutrition Labels: Teaches how to read and interpret food labels, focusing on serving sizes, calorie intake, and nutrients to limit or include.
Tips for Healthy Eating: Offers practical advice such as incorporating a variety of foods, practicing moderation, staying hydrated, and eating mindfully.
Benefits of Regular Exercise:
Physical Benefits: Discusses how exercise aids in weight management, muscle and bone health, cardiovascular health, and flexibility.
Mental Benefits: Explains the psychological advantages, including stress reduction, improved mood, and better sleep.
Tips for Staying Active:
Encourages consistency, variety in exercises, setting realistic goals, and finding enjoyable activities to maintain motivation.
Maintaining a Balanced Lifestyle:
Integrating Nutrition and Exercise: Suggests meal planning and incorporating physical activity into daily routines.
Monitoring Progress: Recommends tracking food intake and exercise, regular health check-ups, and provides tips for achieving balance, such as getting sufficient sleep, managing stress, and staying socially active.
1. Tess Wiskel, MD
EMRA Health Policy Committee
Substance Abuse in the
Emergency Department
Presented by
Emergency Medicine Residents’ Association, 2016
2. Learning Objectives
• Define substance abuse and significance
• Understand the burden of various substances
of abuse in the Emergency Department
• Learn basics of prescription opiate crisis and
new guidelines for prescribers
3. Hospital Based Emergency Care: At
the Breaking Point
• EMTALA requires treatment of all patients
• Substance abuse patients are frequent ED
users and require intensive resource use
Institute of Medicine, 2006
4. Burden of Drug Visits
in Emergency Department
• Over 5 million ED visits related to drugs
annually
– total 125 million visits in 2011
• Increase of 100 % from 2004
Drug Abuse Warning Network, 2011
5. Substance Abuse Defined
• WHO definition
– “the harmful or hazardous use of psychoactive
substances, including alcohol and illicit drugs”
• DSM-5 definition
– 10 classes of drugs, range mild to severe, fit within
11 criteria of: impaired control, social impairment,
risky use, and pharmacological criteria
World Health Organization, 2016
6. Drug Misuse/Abuse ED Visits
• Total 2.5 million ED visits for drug
abuse/misuse
– 1.25 million involved illicit drugs
– 1.24 million involved nonmedical use of
pharmaceuticals
– 0.61 million involved drugs combined with alcohol
• Between 2009 and 2011 visits
– increased by 19 % for all drugs misuse/abuse
Drug Abuse Warning Network, 2011
8. • Over 1% ED visits annually primary diagnosis
• Three times more in men than women
• Increasing rates of hospitalization for alcohol
dependence syndrome
• Comorbid conditions: psychoses and drug
dependence, injury
Alcohol
NATIONWIDE EMERGENCY DEPARTMENT SAMPLE (NEDS) AND NATIONWIDE INPATIENT SAMPLE (NIS), 2013
9. Alcohol
• 0.61 million ED visits annually
– 58 % with illicit drugs
– 56% with pharmaceuticals
• Underage drinking
– 440,000 drug abuse ED visits, 40% involving
alcohol
– Stable from 2004 to 2011
Drug Abuse Warning Netwok, 2011
10. Illicit Drugs
• 1.25 million ED visits annually
• Highest rates for cocaine and marijuana abuse
• Increased by 29% from 2009 to 2011
Drug Abuse Warning Network, 2011
11. Non Medical Use of
Pharmaceutical Drugs
• 1.2 million ED visits annually
• 46 percent pain relievers
– 29 percent opiate pain relievers
• Increase 132 % from 2004 to 2011
– Opiate involvement increased 183 %
Drug Abuse Warning Network, 2011
12. ED Visits for Nonmedical Use of Opiates
Drug Abuse Warning Network, 2004-2008
13. Opiate Public Health Crisis
• Opiate prescribing increasing
• Death rates from opiates increasing
• New guidelines released by CDC for
prescribers
MMWR / March 18, 2016 / Vol. 65 / No. 1
14. “Emergency physicians see first hand
the tragic consequences of opioid
misuse and addiction and applaud the
Centers for Disease Control and
Prevention for taking an important
step forward in addressing this public
health epidemic.”
Jay Kaplan, MD, FACEP
ACEP President
15. CDC Opiate Prescription Guidelines
• Chronic pain treatment determining initiation
and continuation
• Selection, dosage,
follow-up and
discontinuation
• Assessing risk and
harms throughout
treatment
MMWR / March 18, 2016 / Vol. 65 / No. 1
16. Combatting the Opiate Crisis
• Educating patients, providers
• Prescription drug monitoring programs
• Screening, Brief Intervention and Referral to
Treatment programs
• Proper medication disposal
• Enforcement
Office of National Drug Control Policy, 2011
17. Response to Opiate Crisis
• Given increase in use of opioid medications and
increasing deaths, many above interventions
implemented
• Rates of prescription opioid deaths and abuse
increased from 2002 to 2010 but decreased from
2011 to 2013
• Illicit opiate use increasing: heroin death rates
increasing over same time period
N Engl J Med 2015;372:241-8.
18. Resources
• CDC opiate prescription guidelines MMWR / March 18,
2016 / Vol. 65 / No. 1 .
http://www.cdc.gov/mmwr/volumes/65/rr/rr6501e1.h
tm
• CDC drug and addiction resources:
http://www.cdc.gov/pwud/addiction.html
• Drug Abuse Warning Network, 2011. Estimates of
Drug-Related Emergency Visits.
http://www.samhsa.gov/data/sites/default/files/DAW
N2k11ED/DAWN2k11ED/DAWN2k11ED.pdf
Per the institute of medicine report in 2006, stating Eds are “at a breaking point”, one component is resource use. EMTALA law passed in 1986, emergency physicians have a requirement to treat all patients, but are also strained to do so with overcrowding, and under-reimbursement.
Substance users are frequent users of the ED , and high use of resources, including inpatient admissions, and frequently uninsured. They also tend to require more resources in the ED and frequently have unmet treatment needs, such as referrals for behavior change and continued care. Also all numbers tend to be underestimates, as separate studies indicate higher prevalence of substance abuse and no diagnosis recorded. (AHRQ HCUP, IOM report).
Coffey RM, Houchens R, Chu BC, Barrett M, Owens P, Stocks C, Vandivort-Warren R, Buck J, Emergency Department Use for Mental and Substance Use Disorders.
Online August 23, 2010, U.S. Agency for Healthcare Research and Quality (AHRQ). Available: http://www.hcup-us.ahrq.gov/reports.jsp
Hospital-based emergency care : at the breaking point / Committee on the Future of Emergency Care in the United States Health System, Board on Health Care Services. Copyright 2007 by the National Academy of Sciences. Institute of Medicine.
data from DAWN- drug abuse warning network that is a public health surveillance system of the substance abuse and mental health services administration; ended in 2011, new systems replacing, last data 2011;
Emphasize importance of drug related visits to emergency medicine; this is all drugs, not just abuse/misuse (includes adverse effects, seeking detox, abuse of all drugs, etc). Sheer number of visits related to drugs; over 5 million, or 1,626 ED visits per 100,000 population, which is increasing; a 100 percent increase since 2004.
Substance Abuse and Mental Health Services Administration, Drug Abuse Warning Network, 2011: National Estimates of Drug-Related Emergency Department Visits . HHS Publication No. (SMA) 13-4760 , DAWN Series D-39 . Rockville, MD: Substance Abuse and Mental Health Services Administration, 2013.
WHO definition
World Health Organization; http://www.who.int/topics/substance_abuse/en/
DSM definition includes 10 classes of drugs: alcohol, caffeine, cannabis, hallucinogens, inhalants, opioids, sedatives hypnotics and anxiolytics, stimulants, tobacco, other
Fit within at least two of 11 criteria in above four categories: impaired control : 1) increasing amounts of use 2) desire to cut down 3) time obtaining/using substance 4) craving
Social impairment 5) failure to fulfill obligations 6) social or interpersonal problems 7) give up activities
Risky use 8) physically hazardous situations using 9) continued use despite knowledge of risks
Pharmacological 10) tolerance 11) withdrawal
Different definition of substance abuse than substance induced disorder which includes intoxication, withdrawal and other induced mental disorders
DSM-5. 2013 American Psychiatric Association; http://www.dsm5.org/Pages/Default.aspx;
Of the 5 million drug visits, approximately half were for drug misuse/abuse. -2011 had 2.5 million ED visits resulted from drug misuse or abuse, which is 790 ED visits per 100,000 population
Drug misuse/abuse defined as visits from the following four analytic groups: illicit drug visits, nonmedical use of pharmaceuticals, alcohol-related visits, and underage drinking. A visit can appear in multiple sub groups but is only counted for once in the main group of all drug misuse/abuse; includes visits requesting detox or suicide attempts related to these categories
Of all drug abuse/misuse ED visits; approximately 51% of involved illicits and nonmedical pharmaceuticals; 25% drugs combined with alcohol
Substance Abuse and Mental Health Services Administration, Drug Abuse Warning Network, 2011: National Estimates of Drug-Related Emergency Department Visits . HHS Publication No. (SMA) 13-4760 , DAWN Series D-39 . Rockville, MD: Substance Abuse and Mental Health Services Administration, 2013.
Splitting the data by age group and drug misuse/abuse (dark blue) versus all drug visits (light blue); data from DAWN 2011
“In 2011, drug-related visits range from a low of 288 visits per 100,000 population aged 6 to
11 to a high of 2,477 visits per 100,000 population aged 18 to 20. “
Substance Abuse and Mental Health Services Administration, Drug Abuse Warning Network, 2011: National Estimates of Drug-Related Emergency Department Visits . HHS Publication No. (SMA) 13-4760 , DAWN Series D-39 . Rockville, MD: Substance Abuse and Mental Health Services Administration, 2013.
Data based on nationwide emergency department sample- NEDS 2006-2010, largest ED nationwide database, however has inherent limitations, data based on ICD codes for diagnosis.
Specifically looking at alcohol listed as first diagnosis : 1.1276 percent of ED visits in 2010 for those ages 12 and older had a first-listed diagnosis of alcohol-related conditions. More in men males (1.8767) was about 3 times as high as that of females (0.5629).
Increasing rates of hospitalization, impact on ED? “the number of hospitalizations among male patients ages 12 and older with a diagnosis of alcohol dependence syndrome increased from 625,651 in 2006 to 739,813 in 2010. The number of hospitalizations among female patients with a diagnosis of nondependent abuse of alcohol increased from 193,942 in 2006 to 220,499 in 2010.”
Many with comorbid drug and mental health conditions: “ED visits by patients ages 12–20 with a first-listed diagnosis of alcohol-related conditions in 2009, 10.4149 percent also had a drug related diagnosis. The percentage increased in the 21–24 age group (11.7141) and the 25–44 age group (13.7157), then dropped in the 45–64 age group (9.2758) and was lowest (2.8101) in the 65+ age group.” “2010, among hospitalizations of patients ages 12 and older, 46.6544 percent of those with an all-listed diagnosis of alcohol dependence syndrome also had a co-occurring mental health-related diagnosis.”
Comorbid injury diagnosis as well by age group: “2010, among ED visits by patients ages 12– 20, 28.9635 percent of those with an all-listed diagnosis of nondependent abuse of alcohol also had any injury-related diagnosis. The percentage increased in the 21–24 age group (38.7219), -28-then dropped in the 25–44 and 45–64 age groups (30.3525 and 23.4314, respectively) and increased slightly in the 65+ age group (26.3012). Notably, the percentages of co-occurring injuries declined significantly between 2006 and 2010 for the two youngest groups (12–20 and 21–24) but remained almost unchanged for the older age groups.”
ALCOHOL-RELATED EMERGENCY DEPARTMENT VISITS AND HOSPITALIZATIONS AND THEIR CO-OCCURRING DRUG-RELATED, MENTAL HEALTH, AND INJURY CONDITIONS IN THE UNITED STATES: FINDINGS FROM THE 2006–2010 NATIONWIDE EMERGENCY DEPARTMENT SAMPLE (NEDS) AND NATIONWIDE INPATIENT SAMPLE (NIS). September 2013. NIH
Of the total alcohol related visits, the majority also involved other drugs. “ Among all visits involving illicit drugs, about 30 percent also involved alcohol; higher levels of alcohol involvement were found for visits involving ketamine (72%). Among all visits involving pharmaceuticals, 25 percent also involved alcohol. Alcohol was present in 38.6 percent of visits involving penicillin, 38 percent of visits involving CNS stimulants, and 31 percent of visits involving antidepressants. Just under half of the patients received follow-up care.”
“The rate of medical emergencies involving alcohol was 287 visits per 100,000 population aged 12 to 17 and 858 per 100,000 population aged 18 to 20,
almost a threefold difference.” by age for underage drinking.
Substance Abuse and Mental Health Services Administration, Drug Abuse Warning Network, 2011: National Estimates of Drug-Related Emergency Department Visits . HHS Publication No. (SMA) 13-4760 , DAWN Series D-39 . Rockville, MD: Substance Abuse and Mental Health Services Administration, 2013.
Illicits includes: “limited or no therapeutic value and are generally illegal if taken without a prescription. These substances include cocaine, heroin, marijuana, synthetic cannabinoids, amphetamines, methamphetamine, MDMA (Ecstasy), GHB (gamma-Hydroxybutyric acid), flunitrazepam (Rohypnol® ), ketamine, LSD, PCP, and hallucinogens. Visits involving the inhalation of substances for their psychoactive properties (e.g., sniffing model airplane glue) are included.
Cocaine and marijuana rates: 162 and 146 ED visits per 100,000 population, respectively
Visits ended in admission to the hospital (24%), transfer to another health care facility (10%), or referral to a drug detox/dependency program (6%).
Substance Abuse and Mental Health Services Administration, Drug Abuse Warning Network, 2011: National Estimates of Drug-Related Emergency Department Visits . HHS Publication No. (SMA) 13-4760 ,DAWN Series D-39 . Rockville, MD: Substance Abuse and Mental Health Services Administration, 2013.
Any type of nonmedical use included, including taking more than prescribed, another individuals drug, taking a drug obtained illegally, poisoning, etc.
Drugs include: pain relievers= opiate- oxycodone, hydrocodone, methadone, Tylenol, NSAIDs; also anxiolytics, sedatives, hypnotics, psychotherapeutics, CV drugs, muscle relaxants, and anticonvulsants. The highest percentage of drugs were pain relievers and also had the highest rise.
Largest rise in opiate pain relievers, up 183%. Increase in CNS stimulants as well (ADHD drugs) 85% from 2009 to 2011.
Follow up for 40 % visits.
Substance Abuse and Mental Health Services Administration, Drug Abuse Warning Network, 2011:National Estimates of Drug-Related Emergency Department Visits . HHS Publication No. (SMA) 13-4760 ,DAWN Series D-39 . Rockville, MD: Substance Abuse and Mental Health Services Administration, 2013.
Showing the specific types of opiate prescription drugs, which were the highest increasing category of non medical use of pharmaceuticals, most in oxycodone, hydrocodone and methadone. DAWN and CDC analyzed increasing nonmedical use of select prescription drugs. Rates of opioid analgesics increasing over the years at 111%, more than doubling; at the end of this time period in 2008 were equal to the amount of ED visits for illicit drugs.
Of note, the rates of nonmedical benzodiazepine use were also increasing, though at slower rates, by 89% from 2004-2008.
Emergency Department Visits Involving Nonmedical Use of Selected Prescription Drugs- United States 2004-2008. MMWR / June 18, 2010 / Vol. 59 / No. 23
Substance Abuse and Mental Health Services Administration, Drug Abuse Warning Network, 2011: National Estimates of Drug-Related Emergency Department Visits . HHS Publication No. (SMA) 13-4760 , DAWN Series D-39 . Rockville, MD: Substance Abuse and Mental Health Services Administration, 2013.
Per CDC, opiate prescriptions increased increased by 7.3% from 2007 to 2012. “From 1999 to 2014, more than 165,000 persons died from overdose related to opioid pain medication in the United States. In the past decade, while the death rates for the top leading causes of death such as heart disease and cancer have decreased substantially, the death rate associated with opioid pain medication has increased markedly “
- CDC released primary doctor prescribing guidelines to help battle the pain reliever crisis
Dowell et al. CDC Guidelines for Prescribing Opioids for Chronic Pain – United States 2016. MMWR / March 18, 2016 / Vol. 65 / No. 1 US Department of Health and Human Services/Centers for Disease Control and Prevention
President of ACEP on March 2016 in response to the CDC release of opiate prescription guidelines for primary care doctors. Agrees with new step in addressing the epidemic, as well as restricting acute pain rx to less than 7 days, supporting drug monitoring programs and balancing risks and benefits of immediate needs and long term risk of opiate dependence.
Source: American College of Emergency Physicians | News Room “Nation’s Emergency Physicians Applaud CDC Opioid Guidelines” Mar 16, 2016
Basic tenets of the CDC opiate prescription guidelines- does not apply to active cancer, palliative and end of life care: start with non-opiates, discuss treatment goals, risks v. benefits; immediate acting over long acting; lowest effective dose; in acute pain should prescribe for 3-7 days at most; evaluate benefits and harms of increasing dosage or duration of treatment for originally acute pain; mitigate risks, by prescribing naloxone, review drug monitoring programs, use urine drug testing, avoid concomitant benzodiazepine prescriptions, offer treatment (such as buprenorphine) for opioid use disorder.
Dowell et al. CDC Guidelines for Prescribing Opioids for Chronic Pain – United States 2016. MMWR / March 18, 2016 / Vol. 65 / No. 1 US Department of Health and Human Services/Centers for Disease Control and Prevention
A summary from the Office of National Drug Control Policy of the programs underway to combat the prescription drug crisis with the prescription drug abuse prevention plan:
-education: educating providers who request DEA registration, curricula in school, clinical guidelines; educate parents and youth through the Opioid Risk Evaluation and Mitigation Strategy
-prescription drug monitoring programs detect and avert abuse of prescription drugs; track controlled substances
-SBIRTs: help healthcare providers identify and prevent prescription drug abuse problems in primary healthcare settings by working with healthcare providers to increase awareness and training
-proper medication disposal: 70% people using pharmaceuticals nonmedicallly received from friends or family
-enforcement: stop illegal prescribing and doctor shopping
Epidemic: Responding to America’s Prescription Drug Abuse Crisis. Office of National Drug Control Policy, 2011; http://www.cdc.gov/pwud/addiction.html
Data from Researched Abuse, Diversion, and Addiction-Related Surveillance (RADARS)- measures rates from drug diversion investigators, poison centers, substance treatment centers and college students. Interventions include prescription monitoring programs being legislated in 49 states and new abuse programs with decreasing prescribing rates. Rates of availability of prescription drugs increased from 90s to 2010 and then began decreasing with resultant decrease in abuse and adverse outcomes.
Dart et al. Trends in Opioid Analgesic Abuse and Mortalitiy in the United States. N Engl J Med 2015;372:241-8. DOI: 10.1056/NEJMsa1406143